Press Releases

Date Title and Summary
Toggle Summary Accuray Reports Fiscal 2019 First Quarter Financial Results
SUNNYVALE, Calif. , Oct. 30, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2019 ended September 30, 2018 . Company Highlights China Ministry of Health confirms Type A and B quota and licenses Gross orders increased 10
Toggle Summary Accuray Showcases Radiation Therapy Innovations Designed to Improve What's Possible for Patients at ASTRO 2018
SUNNYVALE, Calif. , Oct. 17, 2018 /PRNewswire/ -- Building on its heritage of patient-first innovation, at this year's ASTRO ( American Society for Radiation Oncology ) Annual Meeting, Accuray Incorporated (NASDAQ: ARAY) will showcase radiation therapy solutions designed to enable clinicians to
Toggle Summary Accuray To Report Fiscal 2019 First Quarter Financial Results On October 30, 2018
SUNNYVALE, Calif. , Oct. 11, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2018 on Tuesday, October 30, 2018 after the market close.  Management will host a conference call to review the first quarter results at 1:30 p.m.
Toggle Summary Technische Universität München Hospital is First in Germany to Treat Cancer Patients with Accuray Radixact® System
Versatile, Easy-to-Use System Offers Patients Access to Technologically Advanced Cancer Care SUNNYVALE, Calif. , Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the
Toggle Summary HCG is First in India to Treat Cancer Patients Using the Accuray Radixact® System
Adoption of Innovative Radiation Therapy Technology Reinforces South Asian Cancer Center's Position as Pioneer in Patient Care SUNNYVALE, Calif. , Oct. 4, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the clinical team at Healthcare Global Enterprises (HCG) EKO,
Toggle Summary Largest Prostate SBRT Studies to Date Show Accuray CyberKnife® System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
Recently Published Data Demonstrate Benefits of CyberKnife Treatment for Both Low- and Intermediate-Risk Patients at Five Years Post-Treatment SUNNYVALE, Calif. , Sept. 25, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that published data from two prospective,
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2018 Financial Results
SUNNYVALE, Calif. , Aug. 16, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2018 . Q4 Fiscal 2018 and Recent Operating Highlights Gross orders increased 12 percent to $96.4 million Revenue increased to
Toggle Summary Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System
Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System SUNNYVALE, Calif. , July 25, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Addenbrooke's Hospital clinical team has treated the first
Toggle Summary Joseph E. Whitters Appointed to Accuray Board of Directors
SUNNYVALE, Calif. , July 19, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Joseph E. Whitters to the company's Board of Directors, effective as of July 16, 2018 . In addition, he will serve on the Board's Audit Committee. With Mr.
Toggle Summary Accuray To Report Fiscal 2018 Fourth Quarter And Full Year Financial Results On August 16, 2018
SUNNYVALE, Calif. , July 19, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2018 ended June 30, 2018 on Thursday, August 16, 2018 after the market close. Management will host a conference call to review the fourth quarter results